EPITHERAPEUTICS

epitherapeutics-logo

EpiTherapeutics is developing novel innovative cancer drugs based on epigenetics, a therapeutic area researched by renowned scientist Professor Kristian Helin and his group at Biotech Research & Innovation Centre (BRIC) at University of Copenhagen. EpiTherapeuticsโ€™ development programs are focused on enzymes involved in the regulation of transcription in cancer.

#People #Financial #Website #More

EPITHERAPEUTICS

Industry:
Biotechnology Medical

Founded:
1987-01-01

Address:
Foster City, California, United States

Country:
United States

Website Url:
http://www.epitherapeutics.dk

Total Employee:
5001+

Status:
Active

Contact:
6505225696

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins



Current Advisors List

jasper-bos_image

Jasper Bos Boards of Directors @ Epitherapeutics
Board_member

georges-gemayel_image

Georges Gemayel Chairman of the Board of Directors @ Epitherapeutics
Board_member

Founder


not_available_image

Kristian Helin

Investors List

seed-capital_image

Seed Capital

Seed Capital investment in Funding Round - Epitherapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Funding Round - Epitherapeutics

Official Site Inspections

http://www.epitherapeutics.dk

  • Host name: 22.167.207.35.bc.googleusercontent.com
  • IP address: 35.207.167.22
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Epitherapeutics"

EpiTherapeutics Company Profile 2024: Valuation, Investors

EpiTherapeutics was founded in 2008. Where is EpiTherapeutics headquartered? EpiTherapeutics is headquartered in Copenhagen, Denmark. What is the size of โ€ฆSee details»

Epitherapeutics - Crunchbase Company Profile & Funding

Organization. Epitherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Foster City, California, United States; 5001-10000; โ€ฆSee details»

EPITHERAPEUTICS ApS :: Denmark - OpenCorporates

Free and open company data on Denmark company EPITHERAPEUTICS ApS (company number 30523067), c/o Plesner Advokatpartnerselskab Amerika Plads 37, København Ø, 2100. ... 25 โ€ฆSee details»

EpiTherapeutics - Genevia Technologies

EpiTherapeutics. Epitherapeutics was founded by Professor Kristian Helin and key members of his group at Biotech Research & Innovation Centre (BRIC) at University of Copenhagen. The โ€ฆSee details»

EpiTherapeutics ApS Overview | SignalHire Company Profile

EpiTherapeutics is developing novel innovative cancer drugs based on world leading research in epigenetics. ... Organization Website: epitherapeutics.com ... Pharma: Headquarters Location: โ€ฆSee details»

Epitherapeutics ApS | 2100 Copenhagen, Capital Region of โ€ฆ

Epitherapeutics is a leading epigenetic drug discovery company with a focus on oncology and with several programs in lead optimization. Find investment information and connect with โ€ฆSee details»

Epitherapeutics - The Org

EpiTherapeutics is developing novel innovative cancer drugs based on epigenetics. Industries. Biotechnology, Health CareSee details»

EpiTherapeutics ApS: Drug pipelines, Patents, Clinical trials - Synapse

Explore EpiTherapeutics ApS with its drug pipeline, therapeutic area, technology platform, 3 literature.See details»

Epitherapeutics - Drug pipelines, Patents, Clinical trials - Synapse

Explore Epitherapeutics with its drug pipeline, therapeutic area, technology platform, .See details»

Organization | Epitherapeutics

Epitherapeutics Report issue For profit Founded: Copenhagen Denmark (2008)See details»

EpiTherapeutics - Products, Competitors, Financials, Employees ...

EpiTherapeutics is developing novel innovative cancer drugs based on the world leading research in epigenetics conducted by Professor Kristian Helin and his group at Biotech Research & โ€ฆSee details»

EpiTherapeutics ApS:Company Profile & Technical โ€ฆ

EpiTherapeutics is a company that provides Histone, Medicine, Histone Demethylases and more. EpiTherapeutics is headquartered in DK ZE. EpiTherapeutics was founded in 2008. โ€ฆSee details»

EpiTherapeutics - VentureRadar

EpiTherapeutics is engaged in the development of novel innovative cancer drugs. EpiTherapeutics' development programs are focused on enzymes involved in the regulation of โ€ฆSee details»

EpiTherapeutics - CoBee Company Profile & Funding Rounds

EpiTherapeutics is a biopharmaceutical firm that develops cancer drugs based on the research in epigenetics field. Business Model: Revenue: $0. Employees: 11-50. ... Country: DK. Financial โ€ฆSee details»

EPITHERAPEUTICS ApS | BiQ Insight - data.biq.dk

EPITHERAPEUTICS ApS: Adresse: Plesner Advokatpartnerselskab Amerika Plads 37 2100 København Ø Danmark: Kort: Se på Google Maps: Email: [email protected]: Telefon: โ€ฆSee details»

EpiTherapeutics - The Lundbeck Foundation

EpiTherapeutics Discovery of new pharmaceuticals for the treatment of cancer within the field of epigenetics. Lundbeckfonden BioCapital. Invested. 2010 Acquired by Gilead in 2015. โ€ฆSee details»

EpiTherapeutics - Company Profile - Tracxn

Oct 22, 2024 EpiTherapeutics - Developer of therapies to treat cancer. Acquired by Gilead. Raised a total funding of $23M over 6 rounds from 6 investors. EpiTherapeutics has 328 โ€ฆSee details»

EPITHERAPEUTICS ApS - Profiler.dk

EPITHERAPEUTICS ApS (CVR: 30523067) er aktiv indenfor Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900).See details»

EpiTherapeutics โ€“ Funding, Valuation, Investors, News | Parsers VC

EpiTherapeutics is a biopharmaceutical company developing novel innovative cancer drugs based on the world leading research in the field of epigenetics. EpiTherapeutics' development โ€ฆSee details»

Gilead Sciences Acquires EpiTherapeutics

May 6, 2015 FOSTER CITY, Calif. & COPENHAGEN, Denmark--(BUSINESS WIRE)--May 6, 2015-- Gilead Sciences, Inc. (NASDAQ:GILD) and EpiTherapeutics ApS, a privately-held โ€ฆSee details»

linkstock.net © 2022. All rights reserved